Caden Capital Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$199K Hold
946
2.4% 32
2026
Q1
$209K Sell
946
-2,226
-70% -$545K 2.58% 27
2025
Q4
$804K Sell
3,172
-121,554
-97% -$30.5M 1.81% 2
2025
Q3
$30.9M Sell
124,726
-15,000
-11% -$3.59M 12.51% 5
2025
Q2
$33.6M Buy
139,726
+114,726
+459% +$26.7M 11.16% 3
2025
Q1
$5.67M Sell
25,000
-150,358
-86% -$33.1M 1.75% 11
2024
Q4
$36M Buy
175,358
+95,379
+119% +$20.9M 11% 5
2024
Q3
$19.4M Sell
79,979
-33,660
-30% -$7.87M 6.54% 6
2024
Q2
$24.9M Buy
113,639
+26,696
+31% +$5.8M 9.02% 7
2024
Q1
$19.5M Buy
86,943
+4,631
+6% +$1.04M 7.18% 8
2023
Q4
$18.1M Buy
82,312
+36,576
+80% +$7.74M 6.58% 8
2023
Q3
$10M Sell
45,736
-36,277
-44% -$8.21M 2.82% 14
2023
Q2
$18.5M Sell
82,013
-14,913
-15% -$2.98M 4.68% 10
2023
Q1
$18.5M Sell
96,926
-14,230
-13% -$2.75M 5.56% 10
2022
Q4
$20.5M Buy
+111,156
New +$19.5M 7.31% 6

Other funds holding STE

Caden Capital Partners's STE Position: Q2 2026 in Review

Caden Capital Partners held its Steris (STE) position steady in Q2 2026 at 946 shares worth $199K. The position accounts for 2.4% of the portfolio, ranked #32.

Caden Capital Partners first reported a position in STE in Q4 2022 and has held it in 15 quarters since. The position peaked at $36M in Q4 2024. 828 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Caden Capital Partners held 946 shares of Steris worth $199K as of Q2 2026.
  • Caden Capital Partners left its Steris share count unchanged in Q2 2026.
  • Steris made up 2.4% of Caden Capital Partners's portfolio in Q2 2026, its #32 holding.
  • Caden Capital Partners first reported a position in Steris in Q4 2022 and has held it in 15 quarters since.
  • Caden Capital Partners's Steris position peaked at $36M in Q4 2024.
  • 828 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Caden Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.